Cordis acquires Flexible Stenting Solutions, terms not disclosed

theflyonthewall.com

Cordis Corporation, a subsidiary of Johnson & Johnson, said it has completed the acquisition of Flexible Stenting Solutions, a developer of innovative flexible peripheral arterial, venous, and biliary stents. Burrill & Company's Burrill Capital Fund IV is an investor in Flexible Stenting Solutions. Terms of the acquisition were not disclosed.

View Comments (0)